Cerebral small vessel disease (SVD) is usually associated with high blood pressure, and causes 20% of all strokes. It is the main cause of cognitive changes and dementia associated with stroke. Behavioural symptoms such as apathy are also common in patients with SVD.
Using a computer world to help people with aphasia
The effect of cerebrospinal fluid drainage on brain oxygenation and haemodynamics after subarachnoid haemorrhage
Stroke survivors often have very individual hopes for the future, in terms of the goals they would like to achieve. This research will develop and test a Goal setting and Action Planning (G-AP) approach to achieving personal goals through community rehabilitation.
The effect of blood pigments on brain inflammation and survival of nerve cells
Presented at the International Stroke Conference 2016, the final results from the PISTE trial (Pragmatic Ischaemic Stroke Thrombectomy Evaluation) add new evidence for the effectiveness of mechanical clot retri
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.
The aim of this research is to develop and test a simple yet widely-applicable outcome measure for evaluating cognitive rehabilitation after stroke. Consultation with patients and carers will shape the design and content of the measure.
One in five stroke survivors are left with partial or total loss of vision to one side following a stroke. The condition is called hemianopia, and can severely affect a stroke survivor's quality of life.
Last year, the researchers behind the CLOTS 3 trial showed that intermittent pneumatic compression (IPC) sleeves reduced the risk of deep vein thrombosis (DVT) and improved survival in immobile patients with stroke.